Mustang Bio, Inc. (MBIO)Healthcare | Biotechnology | Waltham, United States | NasdaqCM
0.54 USD
-0.01
(-2.272%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.54 0.00 (-0.001%) ⇩ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:45 a.m. EDT
The investment case for this biotechnology firm is effectively nonexistent due to a catastrophic, multi-year destruction of shareholder value. The price history reveals an absolute collapse, with the stock trading at a fraction of its historical value over an eight-year span, and every single year in that window has seen a decline. This consistent annual erosion, totaling nearly 99.98% in losses, signals a business model that has failed to generate sustainable revenue or growth, leaving investors with nothing but capital preservation concerns. Fundamentally, the company is bleeding cash with negative free cash flow and no earnings, while operating at a loss with no return on equity or assets. The lack of any dividend history confirms that there is no income floor to offset the massive capital depreciation. While the recent price action shows minor volatility around the $0.58 level, this is merely noise in a dying asset; the technicals cannot overcome the reality of a company that has lost virtually all its market value over the last decade. There is no catalyst for a turnaround visible in the data, making this a clear avoidance for any time horizon. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.117848 |
| MSTL | 0.125917 |
| AutoETS | 0.128776 |
| AutoARIMA | 0.129402 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 17.04 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.134 |
| Excess Kurtosis | -1.05 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 4,073,667 |
| Forward P/E | -1.54 |
| Beta | 2.05 |
| Website | https://www.mustangbio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.64052284 |
| Address1 | 95 Sawyer Road |
| Address2 | Suite 110 |
| All Time High | 10,012.5 |
| All Time Low | 0.525 |
| Ask | 0.7048 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 15,390 |
| Average Daily Volume3 Month | 127,485 |
| Average Volume | 127,485 |
| Average Volume10Days | 15,390 |
| Beta | 2.048 |
| Bid | 0.3713 |
| Bid Size | 2 |
| Book Value | 0.996 |
| City | Waltham |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.5376 |
| Current Ratio | 1.972 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.55 |
| Day Low | 0.5328 |
| Display Name | Mustang Bio |
| Earnings Timestamp End | 1,755,288,000 |
| Earnings Timestamp Start | 1,754,942,400 |
| Ebitda | -3,505,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 3.16 |
| Enterprise Value | -11,076,720 |
| Eps Forward | -0.35 |
| Eps Trailing Twelve Months | -0.42 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.62724 |
| Fifty Day Average Change | -0.08964002 |
| Fifty Day Average Change Percent | -0.14291184 |
| Fifty Two Week Change Percent | -64.052284 |
| Fifty Two Week High | 1.85 |
| Fifty Two Week High Change | -1.3124001 |
| Fifty Two Week High Change Percent | -0.7094054 |
| Fifty Two Week Low | 0.525 |
| Fifty Two Week Low Change | 0.012600005 |
| Fifty Two Week Low Change Percent | 0.02400001 |
| Fifty Two Week Range | 0.525 - 1.85 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,503,408,600,000 |
| Float Shares | 5,346,938 |
| Forward Eps | -0.35 |
| Forward P E | -1.536 |
| Free Cashflow | -4,272,250 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 4 |
| Fullday Change | -0.0125 |
| Fullday Change Percent | -2.27232 |
| Fullday Price | 0.5365 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.08021 |
| Held Percent Institutions | 0.099259995 |
| Implied Shares Outstanding | 7,577,506 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,736,985,600 |
| Last Split Factor | 1:50 |
| Long Business Summary | Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children's hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts. |
| Long Name | Mustang Bio, Inc. |
| Market | us_market |
| Market Cap | 4,073,667 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_326621488 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -3,033,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,167,627 |
| Open | 0.55 |
| Operating Cashflow | -4,511,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 781 652 4500 |
| Post Market Change | -0.0011000037 |
| Post Market Change Percent | -0.20461379 |
| Post Market Price | 0.5365 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 0.5501 |
| Price Hint | 4 |
| Price To Book | 0.53975904 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.941 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.012500048 |
| Regular Market Change Percent | -2.2723227 |
| Regular Market Day High | 0.55 |
| Regular Market Day Low | 0.5328 |
| Regular Market Day Range | 0.5328 - 0.55 |
| Regular Market Open | 0.55 |
| Regular Market Previous Close | 0.5501 |
| Regular Market Price | 0.5376 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 20,244 |
| Return On Assets | -0.15362 |
| Return On Equity | -0.5812 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 6,732,121 |
| Shares Percent Shares Out | 0.0069 |
| Shares Short | 52,568 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 60,867 |
| Short Name | Mustang Bio, Inc. |
| Short Percent Of Float | 0.0078 |
| Short Ratio | 1.6 |
| Source Interval | 15 |
| State | MA |
| Symbol | MBIO |
| Total Cash | 15,150,000 |
| Total Cash Per Share | 2.0 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.42 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.843365 |
| Two Hundred Day Average Change | -0.30576503 |
| Two Hundred Day Average Change Percent | -0.36255363 |
| Type Disp | Equity |
| Volume | 20,244 |
| Website | https://www.mustangbio.com |
| Zip | 2,453 |